James J. Doherty serves as President and CDO at Acumen Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, James J. Doherty has executed 4 insider transactions totaling $15.1K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 16, 2026 involved receiving (via award) 250,300 shares valued at $0.
James J. Doherty currently holds 250,300 shares of Acumen Pharmaceuticals, Inc. (ABOS), valued at approximately $0. This represents their equity stake as President and CDO.
Based on SEC Form 4 filings, James J. Doherty has been a net seller of ABOS stock. They have purchased $0 and sold $15.1K worth of shares.
James J. Doherty's most recent insider trade was on Jan 16, 2026, when they sold 250,300 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jan 8, 2026 | ABOS | $11.8K | Sale | 6,467 | $1.82 | Discretionary |
| Jan 7, 2026 | ABOS | $3.4K | Sale | 1,700 | $1.99 | Discretionary |